COMMUNIQUÉ DE PRESSE publié le 24/02/2026 à 15:30, il y a 1 mois 8 jours Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitis Sanofi and Regeneron's Dupixent approved in the US as the first medicine for allergic fungal rhinosinusitis, supported by phase 3 study. A breakthrough in treating chronic sinus disease Sanofi Phase 3 Study Dupixent Regeneron Allergic Fungal Rhinosinusitis
COMMUNIQUÉ DE PRESSE publié le 24/02/2026 à 15:30, il y a 1 mois 8 jours Communiqué de presse : Dupixent de Sanofi et Regeneron est approuvé aux États-Unis comme le premier et le seul médicament pour la rhinosinusite fongique allergique Dupixent de Sanofi et Regeneron approuvé par la FDA aux États-Unis pour traiter la rhinosinusite fongique allergique, offrant un soulagement aux patients de tous âges Traitement Sanofi Dupixent Regeneron Rhinosinusite Fongique Allergique
COMMUNIQUÉ DE PRESSE publié le 24/02/2026 à 15:28, il y a 1 mois 8 jours Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.07% interest in JTC plc as of 23-Feb-2026, with 8,748,078 relevant securities owned. Includes purchase of 5,440 1p ordinary securities at 12.99 GBP/unit The Vanguard Group Stock Purchase Securities Ownership Interest Disclosure JTC Plc
COMMUNIQUÉ DE PRESSE publié le 24/02/2026 à 15:27, il y a 1 mois 8 jours Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5.03% stake in Beazley plc. Details of the ownership disclosed according to Code Rule 8.3 Vanguard Group Ownership Disclosure Stake Code Rule 8.3 Beazley Plc
COMMUNIQUÉ DE PRESSE publié le 24/02/2026 à 15:26, il y a 1 mois 8 jours Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses 2.51% ownership in Schroders plc. Position disclosed on 23 Feb 2026. Details in Form 8.3 The Vanguard Group, Inc. Form 8.3 Schroders Plc Ownership Disclosure Financial Securities
COMMUNIQUÉ DE PRESSE publié le 24/02/2026 à 15:26, il y a 1 mois 8 jours Form 8.3 - The Vanguard Group, Inc.: Life Science REIT plc The Vanguard Group, Inc. discloses a 0.94% stake in Life Science REIT plc. Details of securities and derivative transactions provided Vanguard Group Stake Disclosure Securities Transactions Derivative Transactions Life Science REIT Plc
COMMUNIQUÉ DE PRESSE publié le 24/02/2026 à 15:25, il y a 1 mois 8 jours Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.60% interest in Spire Healthcare Group plc. Purchase of 1p ordinary shares at 1.99 GBP per unit on 23 Feb 2026 Disclosure Vanguard Group Spire Healthcare Purchase GBP
COMMUNIQUÉ DE PRESSE publié le 24/02/2026 à 15:24, il y a 1 mois 8 jours Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses 4.92% stake in Just Group plc. Details on ownership, positions, and dealings provided in Form 8.3 submission Form 8.3 Vanguard Group Dealings Ownership Just Group Plc
COMMUNIQUÉ DE PRESSE publié le 24/02/2026 à 15:23, il y a 1 mois 8 jours Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc The Vanguard Group, Inc. discloses a 5.30% interest in LondonMetric Property plc on 23 Feb 2026. Purchased 186,849 securities at 2.13 GBP per unit Securities The Vanguard Group, Inc. LondonMetric Property Plc Disclosure Purchase
COMMUNIQUÉ DE PRESSE publié le 24/02/2026 à 15:23, il y a 1 mois 8 jours Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited The Vanguard Group, Inc. discloses a 5.24% ownership in Picton Property Income Limited, making a purchase of 37,802 securities at 0.87 GBP per unit Vanguard Group Ownership Disclosure Financial Disclosure Securities Purchase Picton Property Income Limited
Publié le 03/04/2026 à 18:46, il y a 1 jour 18 heures Disclosure of Share Capital and Voting Rights as of March 31, 2026
Publié le 03/04/2026 à 18:46, il y a 1 jour 18 heures Déclaration du nombre d’actions et droits de vote au 31 mars 2026
Publié le 03/04/2026 à 18:01, il y a 1 jour 19 heures ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Publié le 03/04/2026 à 18:00, il y a 1 jour 19 heures ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Publié le 03/04/2026 à 18:00, il y a 1 jour 19 heures LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2026
Publié le 02/04/2026 à 22:00, il y a 2 jours 15 heures Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Publié le 02/04/2026 à 18:32, il y a 2 jours 19 heures Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Publié le 02/04/2026 à 15:00, il y a 2 jours 22 heures Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Publié le 02/04/2026 à 14:40, il y a 2 jours 23 heures Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Publié le 02/04/2026 à 14:30, il y a 2 jours 23 heures Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
Publié le 04/04/2026 à 10:07, il y a 1 jour 3 heures Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026
Publié le 04/04/2026 à 02:05, il y a 1 jour 11 heures Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products
Publié le 03/04/2026 à 18:00, il y a 1 jour 19 heures IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL
Publié le 03/04/2026 à 18:00, il y a 1 jour 19 heures IEVA GROUP: MISE EN OEUVRE D’UN CONTRAT DE LIQUIDITE AVEC LE CREDIT INDUSTRIEL ET COMMERCIAL
Publié le 03/04/2026 à 17:45, il y a 1 jour 20 heures Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems